Warning Label Final Guidance Recommends Use Of Numeric Adverse Reaction Rates
This article was originally published in The Pink Sheet Daily
Executive Summary
Also, known or possible hypersensitivity reactions should be listed under contraindications in drug labeling, FDA says in final guidance.